SS-31 (Elamipretide): Mitochondrial-Targeted Peptide Research

SS-31 (also known as elamipretide or Bendavia) is a small, cell-permeable tetrapeptide engineered specifically to concentrate inside mitochondria — a design that sets it apart from most other research peptides, which act at cell-surface receptors rather than penetrating directly into an organelle.

Design and Targeting Mechanism

SS-31 was designed by alternating cationic and aromatic amino acid residues, giving it two key properties:

• ·Positive charge — draws it toward the highly electronegative inner mitochondrial membrane
• ·Aromatic-cationic motif — allows it to concentrate in mitochondria at levels roughly 1,000-fold higher than in the surrounding cytosol, independent of the mitochondrial membrane potential

This targeting mechanism means SS-31 accumulates precisely where oxidative damage originates, rather than acting diffusely throughout the cell.

What SS-31 Does Inside the Mitochondria

The peptide's primary documented mechanism is binding to cardiolipin, a phospholipid unique to the inner mitochondrial membrane that is essential for organizing the electron transport chain complexes.

• ·Cardiolipin stabilization — prevents cardiolipin peroxidation, which otherwise destabilizes the cristae structure and impairs ATP synthesis
• ·Electron transport chain efficiency — preclinical research shows improved coupling of oxidative phosphorylation, meaning more ATP is generated per unit of oxygen consumed
• ·Reduced ROS production — by stabilizing electron flow through the transport chain, SS-31 research models show reduced electron "leakage" that would otherwise generate reactive oxygen species
• ·Mitochondrial membrane potential preservation — helps maintain the electrochemical gradient mitochondria depend on for ATP production

Research Applications

SS-31 has one of the more advanced clinical research pipelines among mitochondria-targeted peptides:

• ·Cardiac research — studied extensively in heart failure and ischemia-reperfusion injury models, where mitochondrial dysfunction is a central driver of tissue damage
• ·Skeletal muscle aging — preclinical research links SS-31 to improved muscle mitochondrial function and reduced age-related muscle fatigue in animal models
• ·Kidney injury models — investigated for protecting renal tubular cells, which are heavily mitochondria-dependent
• ·Neurodegeneration research — mitochondrial dysfunction is a hallmark of Parkinson's and Alzheimer's pathology, making SS-31 a compound of interest in this space

SS-31 vs MOTS-c

Both SS-31 and MOTS-c are studied in mitochondrial longevity research, but they work through very different mechanisms. MOTS-c is a mitochondrial-DNA-encoded signalling peptide that activates AMPK and influences nuclear gene expression, while SS-31 is a synthetic peptide that physically stabilizes mitochondrial membrane structure. See the SS-31 vs MOTS-c comparison for a full mechanism breakdown, or the Tesamorelin vs MOTS-c comparison for how MOTS-c compares to GH-axis peptides.

Reconstitution and Storage

SS-31 is supplied as a lyophilized powder. Reconstitute with bacteriostatic water and store refrigerated at 2–8°C, using within 28–30 days. Store lyophilized powder at -20°C for long-term stability and protect from light exposure.

Shop SS-31 or explore the Longevity Protocol for a research framework combining mitochondria-targeted and gene-expression-targeted longevity peptides.

Note: SS-31 is sold by JA Performance strictly for laboratory and in vitro research use. Not for human consumption.